Poster: CML-030 Do Patients With CML-CP in MMR Still Have a Hope to Receive Nilotinib (Tasigna) While Fasting During Ramadan? An Unanswered Question

Autor:	Mohamed Maher, Abdelhamid Fouad, Mariam ElHaddad, Mohamed Samra, Raafat Abdelfatah, Hossam Kamel
Rok vydání:	2022
Předmět:	Cancer Research Oncology Hematology
Zdroj:	Clinical Lymphoma Myeloma and Leukemia. 22:S146
ISSN:	2152-2650
DOI:	10.1016/s2152-2650(22)00885-0
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::eb44206d25b6945c889d53001da83266 https://doi.org/10.1016/s2152-2650(22)00885-0 Zobrazit plný text záznamu Full Text from ScienceDirect